Business

Dr. Reddy’s Q4 & Full Year FY25 Financial Results

HYDERABAD, India, May 09, 2025--Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the quarter and year ended March 31, 2025.

articleDr. Reddy's Laboratories Ltd.May 9, 202522/company/dr-reddys-laboratories-limited/news/dr-reddys-q4-and-full-year-fy25-financial-results
Dr. Reddy’s Q4 & Full Year FY25 Financial Results

About this update from Dr. Reddy's Laboratories Ltd.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/85ede63f31ce92476c4e87390097068f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TrVtcdAWYrQTuYXcXWlQcQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/85ede63f31ce92476c4e87390097068f","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/M1GZnt6S1p66fwFPI9ts_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/85ede63f31ce92476c4e87390097068f","width":1024,"height":512}},"lazy":false},{"type":"text","content":"HYDERABAD, India, May 09, 2025--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter and year ended March 31, 2025. The information mentioned in this release is based on consolidated financial statements under International Financial Reporting Standards (IFRS).","length":382,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:bottom;padding-left:0.0px;width:37%;","val":[]},{"colspan":"1","rowspan":"1","style":"vertical-align:bottom;padding-left:0.0px;width:1%;","val":[]},{"colspan":"1","rowspan":"1","style":"vertical-align:bottom;padding-left:0.0px;text-align:center;list-style-position:inside;border-right:solid black 1.0pt;width:37%;","val":[{"type":"text","content":"Q4FY25","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"width:1%;","val":[]},{"colspan":"1","rowspan":"1","style":"vertical-align:bottom;padding-left:0.0px;text-align:center;list-style-position:inside;width:24%;","val":[{"type":"text","content":"FY25","length":4,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"padding-left:0.0px;width:37%;","val":[]},{"colspan":"1","rowspan":"1","style":"padding-left:0.0px;width:1%;","val":[]},{"colspan":"1","rowspan":"1","style":"padding-left:0.0px;border-right:solid black 1.0pt;width:37%;","val":[]},{"colspan":"1","rowspan":"1","style":"padding-left:0.0px;width:1%;","val":[]},{"colspan":"1","rowspan":"1","style":"padding-left:0.0px;width:24%;","val":[{"type":...

More updates from Dr. Reddy's Laboratories Ltd.

International Financial Reporting StandardsRevenuesconsolidated financial statementsQoQYoY